文献
J-GLOBAL ID:201802212525434612
整理番号:18A2164909
イブロチニブを中止したマントル細胞リンパ腫(MCL)患者の長期転帰と突然変異プロファイリング【JST・京大機械翻訳】
Long-term outcomes and mutation profiling of patients with mantle cell lymphoma (MCL) who discontinued ibrutinib
著者 (23件):
Jain Preetesh
(Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Jain Preetesh
(Division of Cancer Medicine, the University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Kanagal-Shamanna Rashmi
(Department of Hematopathology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Zhang Shaojun
(Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Ahmed Makhdum
(Department of Leukemia, the University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Ghorab Ahmad
(Department of Leukemia, the University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Zhang Liang
(Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Ok Chi Young
(Department of Hematopathology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Li Shaoying
(Department of Hematopathology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Hagemeister Frederick
(Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Zeng Dongfeng
(Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Gong Tiejun
(Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Chen Wendy
(Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Badillo Maria
(Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Nomie Krystle
(Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Fayad Luis
(Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Medeiros Leonard J.
(Department of Hematopathology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Neelapu Sattva
(Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Fowler Nathan
(Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Romaguera Jorge
(Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Champlin Richard
(Department of Stem cell transplant, the University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Wang Linghua
(Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Wang Michael L.
(Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, TX, USA)
資料名:
British Journal of Haematology
(British Journal of Haematology)
巻:
183
号:
4
ページ:
578-587
発行年:
2018年
JST資料番号:
C0969B
ISSN:
0007-1048
CODEN:
BJHEAL
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)